Father's quota
Father's quota is a term used to describe a policy measure that reserves a certain amount of parental leave specifically for fathers. The concept of Father's quota is primarily used in the context of Nordic countries, where it has been implemented to encourage greater paternal involvement in child-rearing and to promote gender equality in both the domestic and professional spheres.
History[edit | edit source]
The concept of Father's quota was first introduced in Norway in 1993. The policy was designed to encourage fathers to take a more active role in child-rearing by reserving a portion of the parental leave period specifically for them. This was seen as a way to promote gender equality and to challenge traditional gender roles. Since then, other Nordic countries, including Sweden and Iceland, have implemented similar policies.
Implementation[edit | edit source]
In countries where a Father's quota is in place, a certain portion of the total parental leave is reserved exclusively for the father. If the father does not take this leave, it cannot be transferred to the mother, and is instead lost. This is intended to incentivize fathers to take leave and to participate more actively in child-rearing.
The length of the Father's quota varies from country to country. In Norway, for example, the quota is currently 10 weeks. In Sweden, it is 90 days. The quota is typically paid at a rate equivalent to the father's salary prior to the birth of the child.
Impact[edit | edit source]
Research has shown that the introduction of a Father's quota can have a significant impact on parental leave patterns. In countries where a quota is in place, fathers are more likely to take leave and to spend more time caring for their children. This can have a positive impact on gender equality, both in the home and in the workplace.
However, the effectiveness of the Father's quota can depend on a range of factors, including societal attitudes towards gender roles, the availability of affordable childcare, and the level of support provided by employers.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
